Search research articles
Contact Us
Filters
Showing results (21-30 of 133) with videos related to
Page
of 14
Sort By:
Advances in Neurology
|
January 7, 2000
Epidemiologic aspects
D M Togasaki, C M Tanner
Neurology
|
October 1, 1990
Do environmental toxins cause Parkinson's disease? A critical review
C M Tanner, J W Langston
Neurologic Clinics
|
May 1, 1997
Epidemiology of Tourette syndrome
C M Tanner, S M Goldman
The New England Journal of Medicine
|
June 25, 1981
CPK values in Parkinson's disease
C M Tanner, C G Goetz
Advances in Neurology
|
July 20, 1999
Epidemiology of Parkinson's disease
C M Tanner, Y Ben-Shlomo
Neurologic Clinics
|
May 1, 1996
Epidemiology of Parkinson's disease
C M Tanner, S M Goldman
Annals of Neurology
|
April 1, 1982
The electroencephalogram in Tourette syndrome
D Bergen, C M Tanner, R Wilson
Clinical Neuropharmacology
|
April 1, 1987
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis
M Harris, L Nora, C M Tanner
Journal of Neural Transmission. Supplementum
|
October 5, 2006
Nongenetic causes of Parkinson's disease
A R Chade, M Kasten, C M Tanner
Clinical Neuropharmacology
|
January 1, 1984
The reversibility of "permanent" tardive dyskinesia
H L Klawans, C M Tanner, A Barr
Page
of 14
Search research articles
Search
Showing results (21-30 of 133) with videos related to
Sort By:
Page
of 14
Advances in Neurology
|
January 7, 2000
Epidemiologic aspects
D M Togasaki, C M Tanner
Neurology
|
October 1, 1990
Do environmental toxins cause Parkinson's disease? A critical review
C M Tanner, J W Langston
Neurologic Clinics
|
May 1, 1997
Epidemiology of Tourette syndrome
C M Tanner, S M Goldman
The New England Journal of Medicine
|
June 25, 1981
CPK values in Parkinson's disease
C M Tanner, C G Goetz
Advances in Neurology
|
July 20, 1999
Epidemiology of Parkinson's disease
C M Tanner, Y Ben-Shlomo
Neurologic Clinics
|
May 1, 1996
Epidemiology of Parkinson's disease
C M Tanner, S M Goldman
Annals of Neurology
|
April 1, 1982
The electroencephalogram in Tourette syndrome
D Bergen, C M Tanner, R Wilson
Clinical Neuropharmacology
|
April 1, 1987
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis
M Harris, L Nora, C M Tanner
Journal of Neural Transmission. Supplementum
|
October 5, 2006
Nongenetic causes of Parkinson's disease
A R Chade, M Kasten, C M Tanner
Clinical Neuropharmacology
|
January 1, 1984
The reversibility of "permanent" tardive dyskinesia
H L Klawans, C M Tanner, A Barr
Page
of 14